← Open Payments lookup

KRISTINA BRAATEN: Open Payments

NPI 1699420026 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$802 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $802

Food & beverage: $802
CompanyPaymentsAmount
Janssen Biotech, Inc.2$254
Daiichi Sankyo Inc.2$143
E.R. Squibb & Sons, L.L.C.1$110
Janssen Scientific Affairs, LLC1$105
Sandoz Inc.1$80
Amgen Inc.1$48
ABBVIE INC.2$32
Novartis Pharmaceuticals Corporation1$30

Products named: RYBREVANT, DATROWAY, REBLOZYL, DARZALEX, IMDELLTRA (AMG757), VENCLEXTA, KISQALI, Enhertu.

Industry payments across WA — which companies pay providers there.